Shanghai Genomics, Inc.
1 clinical trials · Sponsor
◉ Watch Shanghai Genomics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis (NCT02499562) | Shanghai Genomics, Inc. | 2015-06-25 |
Track Shanghai Genomics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.